Navigation Links
Roberta A. Pagon Receives Lifetime Award in Genetics from March of Dimes

TAMPA, Fla., March 27 /PRNewswire-USNewswire/ -- The founder of a public database that helps doctors analyze the usefulness of genetic tests in making medical decisions is the 2009 recipient of the March of Dimes/Colonel Harland Sanders Award for lifetime achievement in the field of genetic sciences.

Roberta "Bonnie" Pagon, MD, professor of Pediatrics at the University of Washington School of Medicine in Seattle, developed the Web site in 1992 and today is the principal investigator of this National Institutes of Health-funded program. Dr. Pagon has been a medical geneticist for more than 25 years and also is adjunct professor in the University's departments of ophthalmology and medicine. Her clinical work focuses on genetic eye diseases and syndrome delineation - reviewing the symptoms of patients who do not have a diagnosis to see if there might be a new disorder.

"Dr. Pagon is responsible for sharing critical information about the diagnosis and management of genetic diseases with physicians worldwide," said Michael Katz, MD, March of Dimes senior vice president of Research and Global Programs, who will present the award today to Dr. Pagon at the Annual Clinical Genetics Meeting of the American College of Medical Genetics held here. "She is a pioneer in the field of medical genetics, and the March of Dimes is pleased to honor her."

In its 15-year history, has grown to become an important international resource for genetic testing information. The site promotes the appropriate use of genetic testing in patient treatment and personal decision-making. For her work on GeneTests, Dr. Pagon previously received the American Society of Human Genetics 2006 Education Award.

Dr. Pagon also is a consultant to the Regional Genetics Program of Washington State and an attending physician in the Children's Hospital and Regional Medical Center Genetics Clinic. She is a member of the board of directors of the American Board of Medical Genetics (ABMG) and a member of the Clinical Practice Committee of the American College of Medical Genetics (ACMG).

She is the review board coordinator for the Collaboration, Education, and Test Translation (CETT) Program, which promotes the collaborative development of new tests for rare genetic diseases for use by doctors and patients, and supports the collection and storage of genetic test results so they can be used to guide new research.

More information about Dr. Pagon's work can be found online at:

The March of Dimes/Colonel Harland Sanders Award for Lifetime Achievement in the field of genetic sciences is given annually to an individual who has made a significant contribution to the genetic sciences.

The March of Dimes is the leading nonprofit organization for pregnancy and baby health. With chapters nationwide and its premier event, March for Babies(R), the March of Dimes works to improve the health of babies by preventing birth defects, premature birth and infant mortality. For the latest resources and information, visit or

SOURCE March of Dimes
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Chindex International, CEO, Roberta Lipson Named Ernst & Young Entrepreneur Of The Year(R) 2008 Award Finalist in Greater Washington
2. Supermodel Helena Houdova & Roberta Armani Host 2nd Annual Sunflower Children Poker Benefit
3. AAPS Applauds the Resignation of TMB President Roberta Kalafut, Mari Robinson Should Resign Next
4. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
5. DaVita Receives Civil Complaint
6. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
7. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
8. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
9. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
10. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
11. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
Post Your Comments:
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family Medicine's (ABFM) Board ... Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton will ... Dr. Puffer’s retirement at the end of 2018. Upon assuming the role of President ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Lori R. Somekh, ... member of ElderCounsel, a national organization of elder law and special needs planning attorneys. ... and rules. It also provides a forum to network with elder law attorneys nationwide,” ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional ... action towards gender equality at their inaugural Summit in New York City in June. ... a social audience of over 3 million. To watch the Mobilize Women video, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader ... been awarded a contract by the Center for Medicare and Medicaid Services (CMS). ... the enterprise use of Agile methodologies in a consistent and high value manner ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Labs announces the European launch of their new low volume, high ... in Cambridge, U.K on October 4th. The ... with unprecedented speed and sensitivity while using far less sample volume ... ... ...
(Date:9/27/2017)...  Commended for their devotion to personalized service, SMP Pharmacy ... one in the South Florida Business Journal,s 50 Fastest-Growing Companies, ... list, the national specialty pharmacy has found its niche.  To ... soon be honored by SFBJ as the 2017 Power Leader ... to receive his award in October, Bardisa said of the ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology: